LANDRIGAN, MATTHEW D.,O'SHAUGHNESSEY, KRISTA,WOODELL-MAY, JENNIFER,SUTER, DAVID L.
申请号：
CA2916158
公开号：
CA2916158C
申请日:
2014.03.07
申请国别(地区):
CA
年份:
2020
代理人:
摘要：
Methods of treating peripheral vascular disease comparing administering a protein solution site of a defect at least two proteins from the group IL-1ra, sTNF-RI, sTNF-RII, IGF-I, EGF, HGF, PDGF-AB, PDGF-BB, VEGF, TGF-ß1, and sIL-1RII. The solution may also comprise white blood cells, platelets, concentrated bone marrow aspirate, and combinations thereof.
